Influence of drug therapy on the risk of recurrence of ocular toxoplasmosis

2015 ◽  
Vol 100 (2) ◽  
pp. 195-199 ◽  
Author(s):  
Michael Reich ◽  
Matthias D Becker ◽  
Friederike Mackensen
Keyword(s):  
Drug Therapy ◽  
Ocular Toxoplasmosis ◽  
Risk Of Recurrence

scholarly journals Risk of recurrence after discontinuation of antiepileptic drug therapy in children with epilepsy

2014 ◽  
Vol 9 (2) ◽  
pp. 100 ◽  
Author(s):  
Faruk Incecik ◽  
Gulen Mert ◽  
Nurcihan Kiris ◽  
Sakir Altunbasak ◽  
OzlemM Herguner
Keyword(s):  
Drug Therapy ◽  
Antiepileptic Drug ◽  
Risk Of Recurrence ◽  
Antiepileptic Drug Therapy

Risk of Recurrence of Preexisting Ocular Toxoplasmosis during Pregnancy

2014 ◽  
Vol 23 (3) ◽  
pp. 240-245 ◽  
Author(s):  
Michael Reich ◽  
Mira Ruppenstein ◽  
Matthias D. Becker ◽  
Friederike Mackensen
Keyword(s):  
Ocular Toxoplasmosis ◽  
Risk Of Recurrence ◽  
Toxoplasmosis During Pregnancy

scholarly journals Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism

2016 ◽  
Vol 101 (4) ◽  
pp. 1381-1389 ◽  
Author(s):  
Xander G. Vos ◽  
Erik Endert ◽  
A. H. Zwinderman ◽  
Jan G. P. Tijssen ◽  
Wilmar M. Wiersinga
Keyword(s):  
Drug Therapy ◽  
Antithyroid Drug ◽  
Risk Of Recurrence ◽  
Antithyroid Drug Therapy

TIME PATTERNS OF RECURRENCES AND FACTORS PREDISPOSING FOR A HIGHER RISK OF RECURRENCE OF OCULAR TOXOPLASMOSIS

Retina ◽  
2015 ◽  
Vol 35 (4) ◽  
pp. 809-819 ◽  
Author(s):  
Michael Reich ◽  
Mira Ruppenstein ◽  
Matthias D. Becker ◽  
Friederike Mackensen
Keyword(s):  
Ocular Toxoplasmosis ◽  
Risk Of Recurrence ◽  
Time Patterns

Neural Tube Defects

1980 ◽  
Vol 2 (2) ◽  
pp. 58-58
Author(s):  
GERALD S. GOLDEN
Keyword(s):  
Drug Therapy ◽  
Motor Function ◽  
Neural Tube ◽  
Neural Tube Defects ◽  
Recurrence Risk ◽  
Intermittent Catheterization ◽  
Sensory Level ◽  
Risk Of Recurrence

A reader of the article "Neural Tube Defects" (PIR 1:187, December 1979) raised three questions: (1) Is there not newer information to indicate that the risk of recurrence is half of what has been previously quoted in the literature? (2) Does the sensory level defect follow the motor function? (3) Does not intermittent catheterization and drug therapy in the management of urologic problems produce a higher percentage of continence than is presented in this paper? Dr Golden responds as follows: The question of recurrence risk in this country is not clean. Although it is generally recognized that the incidence is lower than in England, data for recurrence risk are not available.

Drug Therapy for ‘Prediabetes’ Held Premature

2009 ◽  
Vol 42 (7) ◽  
pp. 26
Author(s):  
MITCHEL L. ZOLER
Keyword(s):  
Drug Therapy
Sign in / Sign up

Export Citation Format

Share Document